SET7/9 (human recombinant)
|
|
- $601 - $662
- Product name: SET7/9 (human recombinant)
- CAS:
- MF:
- MW: 0
- EINECS:
- MDL Number:
- Synonyms:SET7/9 (human recombinant)
2 prices
Selected condition：
Brand
- Cayman Chemical
Package
- 500μg
- ManufacturerCayman Chemical
- Product number10320
- Product descriptionSET7/9 (human recombinant) ≥95% estimated by SDS-PAGE
- Packaging500μg
- Price$601
- Updated2024-03-01
- Buy
- ManufacturerCayman Chemical
- Product number10320
- Product descriptionSET7/9 (human recombinant) ≥95%estimatedbySDS-PAGE
- Packaging500μg
- Price$662
- Updated2026-04-30
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Cayman Chemical | 10320 | SET7/9 (human recombinant) ≥95% estimated by SDS-PAGE | 500μg | $601 | 2024-03-01 | Buy |
| Cayman Chemical | 10320 | SET7/9 (human recombinant) ≥95%estimatedbySDS-PAGE | 500μg | $662 | 2026-04-30 | Buy |
Properties
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|
Description
Methylation of lysine can promote transcriptional activation or repression and is critical in regulating histone function.1 Lysine residues can be mono-, di-, or tri-methylated, and unlike most SET proteins, SET7/9 is exclusively a mono-methylase.2 SET7/9 methylates histone H3, tumor suppressor p53, and transcription factor TAF10.3 Recently, SET7/9 was shown to catalyze methylation of p53 in response to DNA damage thereby activating p53 for subsequent acetylation.1 SET7/9 is able to modulate p53 activity in a human cancer cell line, implying that it may play a significant role in human tumorigenesis.WARNING This product is not for human or veterinary use.More related product prices
Related product price
-
SET8 (human recombinant)
$401-442